Wicker, no political naïf, brought out the big rhetorical ammo, reminding the senators that it was Jamie Thomson, the University of Wisconsin scientist who first reported isolating the cells in 1998, who said: «
If human embryonic stem cell research does not make you at least a bit uncomfortable, you have not thought about it enough.»
University of Wisconsin scientist, James A. Thomson, who first derived ESCs from embryos, has said «
if human embryonic stem cell research does not make you at least a little bit uncomfortable, you have not thought about it enough.»
Not exact matches
«It's an exciting development, and we await the outcome over the next year to see how well these
cells integrate, and
if there are any potential adverse reactions,» says Mike Cheetham of the Institute of Ophthalmology at University College London, one site where
research is under way into a
human embryonic stem -
cell treatment for AMD.
If that's the case, it is tempting to blame President George W. Bush's restrictions on
research using
human embryonic stem cells (hESCs).
If dealing with the public relations nightmare over its on - off - on funding of Planned Parenthood wasn't enough, the Susan G. Komen for the Cure cancer charity last week also got entangled, somewhat bizarrely, in the debate over
human embryonic stem (ES)
cell research.
Anger about prospects for
human embryonic stem -
cell research might similarly attenuate
if practical applications emerge.
The Society believes that
research involving the transfer of a
human nucleus into an animal egg will lead to important new knowledge about
cell nuclear replacement (CNR) technology and,
if it were to prove possible to produce
embryonic stem cells by this route, would increase understanding of how to programme these
cells to develop into different tissue types.